Evidence map›Paper›PMID 38233146›Full record

ArticleeNeuro2024

Inhibition of ASIC1a Improves Behavioral Recovery after Stroke.

Ariel Armstrong, Tao Yang, Tiandong Leng, Zhi-Gang Xiong

Abstract read
In one paragraph

Article in eNeuro, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ariel ArmstrongDepartment of Neurobiology, Neuroscience Institute, Morehouse School of Medicine, Atlanta, Georgia 30310.ORCID https://orcid.org/0000-0002-4614-8479
Tao YangDepartment of Neurobiology, Neuroscience Institute, Morehouse School of Medicine, Atlanta, Georgia 30310.
Tiandong LengDepartment of Neurobiology, Neuroscience Institute, Morehouse School of Medicine, Atlanta, Georgia 30310.
Zhi-Gang XiongDepartment of Neurobiology, Neuroscience Institute, Morehouse School of Medicine, Atlanta, Georgia 30310 zxiong@msm.edu.

Funding

TISSUE CULTURE MODEL FOR RETINITIS PIGMENTOSA--A MOLECULAR APPROACHR25GM058268 · NIGMS · MOREHOUSE SCHOOL OF MEDICINE · PI HARRIS-HOOKER, SANDRA, STILES, JONATHAN K. · 1998 to 2023
$16.5M
The role of cholesterol metabolic enzyme CYP46A1 and its metabolite 24S-hydroxycholesterol in ischemic stroke.R01NS128018 · NINDS · MOREHOUSE SCHOOL OF MEDICINE · PI TIANDONG LENG · 2022 to 2026
$1.8M
NIGMS NIH HHS R25 GM058268NINDS NIH HHS R01 NS128018
6 · The paper itself

Abstract

Stroke continues to be a leading cause of death and long-term disabilities worldwide, despite extensive research efforts. The failure of multiple clinical trials raises the need for continued study of brain injury mechanisms and novel therapeutic strategies for ischemic stroke. The contribution of acid-sensing ion channel 1a (ASIC1a) to neuronal injury during the acute phase of stroke has been well studied; however, the long-term impact of ASIC1a inhibition on stroke recovery has not been established. The present study sought to bridge part of the translational gap by focusing on long-term behavioral recovery after a 30 min stroke in mice that had ASIC1a knocked out or inhibited by PcTX1. The neurological consequences of stroke in mice were evaluated before and after the stroke using neurological deficit score, open field, and corner turn test over a 28 d period. ASIC1a knock-out and inhibited mice showed improved neurological scores more quickly than wild-type control and vehicle-injected mice after the stroke. ASIC1a knock-out mice also recovered from mobility deficits in the open field test more quickly than wild-type mice, while PcTX1-injected mice did not experience significant mobility deficits at all after the stroke. In contrast to vehicle-injected mice that showed clear-sidedness bias in the corner turn test after stroke, PcTX1-injected mice never experienced significant-sidedness bias at all. This study supports and extends previous work demonstrating ASIC1a as a potential therapeutic target for the treatment of ischemic stroke.

Indexed as

Brain InjuriesIschemic StrokeStrokeAcid Sensing Ion ChannelsAnimalsBrainMiceAcid Sensing Ion ChannelsASIC1 protein, mousebehaviorischemiarecoverystroke

Identifiers

PMID38233146
PMCPMC10866329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.